TLR4 and metabolic dysfunction-associated steatohepatitis: Hepatic TLR4 expression was further proved to be up-regulated in a large cohort of NASH patients when compared with NAFL patients, and this seems to occur in a setting of increased plasma endotoxin and fatty acids [135].